Perkins Capital Management’s Chembio diagnostics, Inc. CEMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-267,980
| Closed | -$796K | – | 111 |
|
|
2021
Q2 | $796K | Sell |
267,980
-21,700
| -7% | -$64.5K | 0.45% | 60 |
|
|
2021
Q1 | $1.02M | Buy |
+289,680
| New | +$1.02M | 0.59% | 52 |
|
|
2020
Q1 | – | Sell |
-171,100
| Closed | -$780K | – | 122 |
|
|
2019
Q4 | $780K | Sell |
171,100
-22,200
| -11% | -$101K | 0.7% | 50 |
|
|
2019
Q3 | $1.18M | Sell |
193,300
-50,000
| -21% | -$306K | 1.02% | 35 |
|
|
2019
Q2 | $1.48M | Sell |
243,300
-29,350
| -11% | -$179K | 1.04% | 30 |
|
|
2019
Q1 | $1.51M | Buy |
272,650
+151,250
| +125% | +$839K | 1% | 32 |
|
|
2018
Q4 | $687K | Buy |
121,400
+27,050
| +29% | +$153K | 0.53% | 61 |
|
|
2018
Q3 | $991K | Sell |
94,350
-200
| -0.2% | -$2.1K | 0.59% | 53 |
|
|
2018
Q2 | $1.05M | Buy |
94,550
+20,050
| +27% | +$223K | 0.75% | 46 |
|
|
2018
Q1 | $596K | Buy |
74,500
+49,000
| +192% | +$392K | 0.54% | 58 |
|
|
2017
Q4 | $209K | Sell |
25,500
-10,000
| -28% | -$82K | 0.2% | 96 |
|
|
2017
Q3 | $220K | Sell |
35,500
-10,950
| -24% | -$67.9K | 0.23% | 81 |
|
|
2017
Q2 | $281K | Sell |
46,450
-3,000
| -6% | -$18.1K | 0.31% | 76 |
|
|
2017
Q1 | $262K | Sell |
49,450
-18,600
| -27% | -$98.5K | 0.27% | 85 |
|
|
2016
Q4 | $463K | Buy |
68,050
+1,350
| +2% | +$9.19K | 0.51% | 68 |
|
|
2016
Q3 | $494K | Buy |
+66,700
| New | +$494K | 0.49% | 67 |
|
|
2013
Q3 | – | Sell |
-54,000
| Closed | -$270K | – | 140 |
|
|
2013
Q2 | $270K | Buy |
+54,000
| New | +$270K | 0.21% | 100 |
|